19 August 2020 (Wednesday) - ASH Update

The American Society of Hematology sent their update today. All rather clinical (rather than technical), and with a serious focus on the money, but something for nothing is always good. 

FDA Approves Oliceridine for Management of Acute Pain
The intravenous opioid is approved for use in hospitals and other controlled clinical settings, not for at-home treatment, at a maximum recommended daily dose of 27 mg.

New Cancer Diagnoses Dropped by Nearly Half During Pandemic
A recent study reported a 46.4% average decline in new cancer diagnoses for six common cancer types between March and April 2020, including a 51.8% drop in new breast cancer cases.

Poll Finds 35% of Americans Would Decline COVID-19 Vaccine
A new Gallup poll found that nearly two-thirds of Americans would agree to receive an FDA-approved COVID-19 vaccine at no cost, with slight disparities according to age, race, and location.

No comments:

Post a comment